LYS228

CAS No. 1810051-96-7

LYS228 ( LYS-228;LYS 228 )

Catalog No. M12777 CAS No. 1810051-96-7

LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LYS228
  • Note
    Research use only, not for human use.
  • Brief Description
    LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.
  • Description
    LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml; LYS228 is stable against Metallo-β-lactamases (MBLs), and shows small or no MIC shifts for most SBLs (serine β-lactamases), including CTX-Ms, KPCs and OXA-types.Bacterial Infection Phase 2 Clinical
  • Synonyms
    LYS-228;LYS 228
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    Bacterial Infection

Chemical Information

  • CAS Number
    1810051-96-7
  • Formula Weight
    518.47
  • Molecular Formula
    C16H18N6O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CC1(C(=O)O)ON=C(C2=CSC(=N2)N)C(=O)NC3C(N(C3=O)S(=O)(=O)O)CN4CCOC4=O
  • Chemical Name
    1-((((Z)-1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropane-1-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Reck F, et al. Bioorg Med Chem Lett. 2018 Feb 15;28(4):748-755.
molnova catalog
related products
  • Methyl α-D-mannopyra...

    Methyl α-D-mannopyranoside can be used as an intermediate for chemical sythesis and can ?target macrophages in anti-tuberculosis inhalation therapy.

  • Cefpiramide acid

    Cefpiramide is a third-generation cephalosporin antibiotic.

  • Clavulanate lithium

    Clavulanate lithium is an inhibitor of β-lactamase.